[1] [1] RIDDER M D, VERELLEN D, VEROVSKI V, et al. Hypoxic tumor cell radiosensitization through nitric oxide［J］. Nitric Oxide, 2008, 19(2): 164-169.

[2] [2] COOK T, WANG Z, ALBER S, et al. Nitric oxide and ionizing radiation synergistically promote apoptosis and growth inhibition of cancer by activating p53［J］. Cancer Research, 2004, 64(21): 8015-8021.

[3] [3] JORDAN B F, SONWEAUX P, FERON O, et al. Nitric oxide as a radiosensitizer: evidence for an intrinsic role in addition to its effect on oxygen delivery and consumption［J］. International Journal of Cancer, 2004, 109(5): 768-773.

[4] [4] FAN W, BU W, ZHANG Z, et al. X-ray radiation-controlled NO-release for on-demand depth-independent hypoxic radiosensitization［J］. Angewandte Chemie International Edition, 2015, 54(47): 14026-14030.

[5] [5] MITRAGOTRI S. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications［J］. Nature Reviews Drug Discovery, 2005, 4(3): 255-260.

[6] [6] SPEED C A. Therapeutic ultrasound in soft tissue lesions［J］. Rheumatology, 2001, 40(12): 1331-1336.

[7] [7] CHOI W, KIM C. Synergistic agents for tumor-specific therapy mediated by focused ultrasound treatment［J］. Biomaterials Science, 2021, 9(2): 422-436.

[8] [8] ZACCAGNA F, ANZIDEI M, SANDOLO F, et al. MRgFUS for liver and pancreas cancer treatments: the umberto I hospital experience［J］. Translational Cancer Research, 2014, 3(5): 430-441.

[9] [9] LI P, ZHENG Y, RAN H, et al. Ultrasound triggered drug release from 10-hydroxycamptothecin-loaded phospholipid microbubbles for targeted tumor therapy in mice［J］. Journal of Controlled Release, 2012, 162(2): 349-354.

[10] [10] SONG X, FENG L, LIANG C, et al. Ultrasound triggered tumor oxygenation with oxygen-shuttle nanoperfluorocarbon to overcome hypoxia-associated resistance in cancer therapies［J］. Nano Letter, 2016, 16(10): 6145-6153.

[11] [11] MARIN A, MUNIRUZZAMAN M, RAPOPORT N. Mechanism of the ultrasonic activation of micellar drug delivery［J］. Journal of Controlled Release, 2001, 75(1): 69-81.

[12] [12] JIN Z K, WEN Y Y, HU Y X, et al. MRI-guided and ultrasound-triggered release of NO by advanced nanomedicine［J］. Nanoscale, 2017, 9(10): 3637-3645.

[13] [13] ZHANG K, XU H, JIA X, et al. Ultrasound-triggered nitric oxide release platform based on energy transformation for targeted inhibition of pancreatic tumor［J］. ACS Nano, 2016, 10(12): 10816-10828.

[14] [14] ZHANG X, DU J F, GUO Z, et al. Efficient near infrared light triggered nitric oxide release nanocomposites for sensitizing mild photothermal therapy［J］. Advanced Science, 2019, 6(3): 1801122-1801131.

[15] [15] ZHANG X, DU J, GUO Z, et al. Efficient near infrared light triggered nitric oxide release nanocomposites for sensitizing mild photothermal therapy［J］. Advanced Science, 2019, 6(3): 1801122-1801132.

[16] [16] HUANG H C, YANG Y, NANDA A, et al. Synergistic administration of photothermal therapy and chemotherapy to cancer cells using polypeptide-based degradable plasmonic matrices［J］. Nanomedicine, 2011, 6(3): 459-473.

[17] [17] TIAN G, ZHANG X, ZHENG X, et al. Multifunctional RbxWO3 nanorods for simultaneous combined chemo-photothermal therapy and photoacoustic/CT imaging［J］. Small, 2014, 10(20): 4160-4170.

[18] [18] YANG H W, LU Y J, LIN K J, et al. EGRF conjugated PEGylated nanographene oxide for targeted chemotherapy and photothermal therapy［J］. Biomaterials, 2013, 34(29): 7204-7214.

[19] [19] GUO M, XIANG H J, WANG Y, et al. Ruthenium nitrosyl functionalized graphene quantum dots as an efficient nanoplatform for NIR-light-controlled and mitochondria-targeted delivery of nitric oxide combined with photothermal therapy［J］. Chemical Communications, 2017, 53(22): 3253-3256.

[20] [20] BAO Y W, HUA X W, LI Y H, et al. Hyperthemia-promoted cytosolic and nuclear delivery of copper/carbon quantum dot-crosslinked nanosheets: multimodal imaging-guided photothermal cancer therapy［J］. ACS Applied Materials & Interfaces, 2018, 10(2): 1544-1555.

[21] [21] YANG S, LI Z, WANG Y, et al. Multifunctional Bi@PPy-PEG core-shell nanohybrids for dual-maging and photothermal therapy［J］. ACS Applied Materials & Interfaces, 2018, 10(2): 1605-1615.

[22] [22] CHEN J, LUO H, LIU Y, et al. Oxygen-self-produced nanoplatform for relieving hypoxia and breaking resistance to sonodynamic treatment of pancreatic cancer［J］. ACS Nano, 2017, 11(12): 12849-12862.

[23] [23] TSAI M F, HSU C, YEH C S, et al. Tuning the distance of rattle-shaped IONP@Shell-in-Shell nanoparticles for magnetically-targeted photothermal therapy in the second near-infrared window［J］. ACS Applied Materials & Interfaces, 2018, 10(2): 1508-1519.

[24] [24] DAI C, CHEN Y, JING X, et al. Two-dimensional tantalum carbide (MXenes) composite nanosheets for multiple imaging-guided photothermal tumor ablation［J］. ACS Nano, 2017, 11(12): 12696-12712.

[25] [25] ZHU J W, WANG W L, WANG X R, et al. Multishell nanoparticles with “linkage mechanism” for thermal responsive photodynamic and gas synergistic therapy［J］. Advanced Healthcare Materials, 2021, 10(10): 2002038.

[26] [26] CAO Y F, LIU M S, CHENG J, et al. Acidity-triggered tumor-targeted nanosystem for synergistic therapy via a cascade of ROS generation and NO release［J］. ACS Applied Materials & Interfaces, 2020, 12(26): 28975-28984.

[27] [27] FAN W, SHEN B, BU W, et al. Design of an intelligent sub-50 nm nuclear-targeting nanotheranostic system for imaging guided intranuclear radiosensitization［J］. Chemical Science, 2015, 6(3): 1747-1753.

[28] [28] SHEN J, HE Q, GAO Y, et al. Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism［J］. Nanoscale, 2011, 3(10): 4314-4322.

[29] [29] RIGANTI C, MIRAGLIA E, VIARISIO D, et al. Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux［J］. Cancer Research, 2005, 65(2): 516-526.

[30] [30] KIM J, LEE Y, SINGHA K, et al. NONOates-polyethylenimine hydrogel for controlled nitric oxide release and cell proliferation modulation［J］. Bioconjugate Chemistry, 2011, 22(6): 1031-1038.

[31] [31] YOO J W, CHOE E S, AHN S M, et al. Pharmacological activity and protein phosphorylation caused by nitric oxide-releasing microparticles［J］. Biomaterials, 2010, 31(3): 552-558.

[32] [32] CHUNG M F, LIU H Y, SUNG H W, et al. A pH-responsive carrier system that generates NO bubbles to trigger drug release and reverse P-glycoprotein-mediated multidrug resistance［J］. Angewandte Chemie International Edition, 2015, 127(34): 10028-10031.

[33] [33] DING Y, MA Y X, DU C, et al. NO-releasing polypeptide nanocomposites reverse cancer multidrug resistance via triple therapies［J］. Acta Biomaterialia, 2021, 123(15): 335-345.

[34] [34] LIU W, ZHONG Y F, LIU L Y, et al. Solution structures of multiple G-quadruplex complexes induced by a platinum (II)-based tripod reveal dynamic binding［J］. Nature Communications, 2018, 9(1): 3496-3504.

[35] [35] WANG X, GUO Z. Targeting and delivery of platinum-based anticancer drugs［J］. Chemical Society Reviews, 2013, 42(1): 202-224.

[36] [36] GUO D, XU S, HUANG Y, JIANG H, et al. Platinum (IV) complex-based two-in-one polyprodrug for a combinatorial chemo-photodynamic therapy［J］. Biomaterials, 2018, 177(2): 67-77.

[37] [37] HAN X, SUN J, WANG Y, et al. Recent advances in platinum (IV) complex-based delivery systems to improve platinum (II) anticancer therapy［J］. Medicinal Research Reviews, 2015, 35(6): 1268-1299.

[38] [38] JOHNSTONE T C, SUNTHARALINGAM K, LIPPARD S J. The next generation of platinum drugs: targeted Pt (II) agents, nanoparticle delivery, and Pt (IV) prodrugs［J］. Chemical Reviews, 2016, 116(5): 3436-3486.

[39] [39] YASUDA H, NAKAYAMA K, WATANABE M, et al. Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma［J］. Clinical Cancer Research, 2006, 12(22): 6748-6757.

[40] [40] FANG L, FENG M C, CHEN F H, et.al. Oleanolic acid-NO donor-platinum (II) trihybrid molecules: targeting cytotoxicity on hepatoma cells with combined action mode and good safety［J］. Bioorganic & Medicinal Chemistry, 2016, 24(19): 4611-4619.

[41] [41] ZHAO J, GOU S H, SUN Y, et al. Nitric oxide donor-based platinum complexes as potential anticancer agents［J］. Chemistry-A European Journal, 2012, 18(45): 14276-14281.

[42] [42] MUNAWEERA I, SHI Y, KONERU B, et al. Nitric oxide-and cisplatin-releasing silica nanoparticles for use against non-small cell lung cancer［J］. Journal of Inorganic Biochemistry: An Interdisciplinary Journal, 2015, 153(1): 23-31.

[43] [43] PRAMANICK S, KIM J, SARAVANAKUMAR G, et al. Synthesis and characterization of nitric oxide-releasing platinum (IV) prodrug and polymeric micelle triggered by light［J］. Bioconjugate Chemistry, 2018, 29(4): 885-897.

[44] [44] GUO R R, TIAN Y, WANG Y J, et al. Near-infrard laser-triggered nitric oxide nanogenerators for the reversal of multidrug resistance in cancer［J］. Advanced Functional Material, 2017, 27(13): 1606398-1606405.

[45] [45] ZHANG H, TIAN X T, SHANG Y, et al. Theranostic Mn-porphyrin metal-organic frameworks for magnetic resonance imaging-guided nitric oxide and photothermal synergistic therapy［J］. ACS Applied Materials & Interfaces, 2018, 10(34): 28390-28398.

[46] [46] SHI S W, LI Y H, LIU J G, et al. Targeted and NIR light-controlled delivery of nitric oxide combined with a platinum (IV) prodrug for enhanced anticancer therapy［J］. Journal of Material Chemistry B, 2019, 7(11): 1867-1874.